D
CRISPR Therapeutics AG CRSP
$54.13 -$0.19-0.35% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -81.18% -86.13% -89.95% 19.31% 18.89%
Total Other Revenue -- -- -- -- --
Total Revenue -81.18% -86.13% -89.95% 19.31% 18.89%
Cost of Revenue -13.24% -12.20% -16.75% -9.54% -12.54%
Gross Profit -35.40% -76.34% -168.89% 23.85% 26.45%
SG&A Expenses 2.15% 3.57% -4.18% -11.77% -19.38%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -11.25% -10.22% -15.14% -9.84% -13.49%
Operating Income -28.63% -58.86% -109.66% 21.54% 25.12%
Income Before Tax -76.26% -77.66% -140.62% 34.38% 37.90%
Income Tax Expenses 49.74% 73.30% 24.20% 145.74% 134.02%
Earnings from Continuing Operations -75.99% -77.61% -138.43% 32.23% 36.09%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -75.99% -77.61% -138.43% 32.23% 36.09%
EBIT -28.63% -58.86% -109.66% 21.54% 25.12%
EBITDA -30.45% -63.16% -120.67% 22.29% 25.97%
EPS Basic -69.20% -67.30% -123.71% 37.49% 39.60%
Normalized Basic EPS -34.61% -67.36% -125.77% 39.50% 41.31%
EPS Diluted -67.70% -65.52% -121.12% 36.73% 39.02%
Normalized Diluted EPS -33.65% -65.95% -123.12% 39.00% 40.89%
Average Basic Shares Outstanding 5.49% 6.74% 6.48% 5.11% 3.72%
Average Diluted Shares Outstanding 4.96% 6.20% 5.94% 5.63% 4.24%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --